Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.48 | 16.13 |
| PEG Ratio (TTM) | -1.84 | 2.12 |
| P/S Ratio (TTM) | 0.77 | 1.48 |
| P/B Ratio (TTM) | 1.46 | 2.42 |
| P/FCF Ratio (TTM) | 6.93 | 12.84 |
| Price to 5YR AVG Earnings Ratio | -13.94 | 0.15 |
| Price to 5YR AVG FCF Ratio | 24.58 | 39.73 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.42% | 8.50% |
| ROE (TTM) | 7.58% | 19.63% |
| Net Profit Margin (TTM) | 3.91% | 11.12% |
| ROIC 5YR AVG | -8.89% | 6.50% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 59.80% | -3,082.94% | -1,803.24% |
| Revenue | -2.53% | -14.10% | 10.68% |
| Net Income | 57.95% | -3,271.38% | -1,912.62% |
| Cash Flow | 20.91% | -58.57% | 177.50% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | 1.89 |
| Quick Ratio (TTM) | 1.63 | 1.35 |
| D/E Ratio (TTM) | 0.14 | 0.70 |
| Interest Coverage (TTM) | -40.86 | 14.06 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 2.67 | 2.99 |
| LTL to 5YR AVG FCF | 0.81 | 8.58 |
| Shares Outstanding Growth 5YR AVG | 6.48% | 7.97% |